Skip to the answer

Remifentanil Uses, Dosage, Side Effects and Interactions

Brand name
Ultiva

Ultiva was the first remifentanil product the FDA approved, in July 1996. An FDA-approved generic with the same active ingredient is listed.

Remifentanil is a very short-acting opioid pain medicine given through a vein (IV) by anesthesia professionals during general anesthesia, monitored anesthesia care, and in the immediate period after surgery.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About RemifentanilType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Remifentanil in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Remifentanil (Ultiva) is an opioid pain medicine given through a vein by anesthesia teams during and just after surgery and procedures. On the market since about 1996, with FDA-approved generics listed, it is a familiar choice when the team wants pain relief that starts fast and fades within minutes, since blood enzymes break it down. Most people notice little beyond some nausea or vomiting afterward, and the team watches for and treats slow heart rate, low blood pressure and muscle stiffness. Its boxed warning is for life-threatening slowed or stopped breathing, plus addiction, abuse and misuse, which is why it is used only where trained staff watch your breathing.

Key Takeaways From the HelloPharmacist Team

  • Expect it as a drip through your IV, run by a pump and adjusted by your anesthesia team; you never give it yourself.
  • Expect its pain relief to wear off within minutes once the drip stops, so your team plans longer-lasting pain control before it ends.
  • Tell your anesthesia team about every medicine you take, especially sedatives, sleep aids, opioids and antidepressants, which can interact dangerously.
  • Skip alcohol for 24 hours after surgery, because it adds to the sleepiness and slowed breathing that opioids can cause.

How we write and review this content: our editorial policy

FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Remifentanil.

Remifentanil can cause serious, life-threatening, or fatal breathing problems, especially when it is started or the amount is increased. Careful dosing is essential.

As an opioid, it also carries risks of addiction, abuse, and misuse, which can lead to overdose and death. Your risk is assessed and rechecked regularly.

Taking it with benzodiazepines or other CNS depressants, including alcohol, may cause profound sedation, breathing trouble, coma, and death. These combinations are reserved for people with no adequate alternatives.

Read the full warning on DailyMed →

Remifentanil by the Numbers

Strengths
2
in one form
Makers and packagers
3
Earliest FDA record
1996
Rank by Medicaid prescriptions
#1,359 of 1,682 drugs
More prescriptions than 19% of the 1,682 drugs we measure
842 prescriptions, Q1–Q4 2025

Patient Information Guide for Remifentanil

What It’s Used For

Remifentanil is an IV opioid pain medicine used around surgery. Remifentanil Hydrochloride for injection and Ultiva share these uses:

  • Pain control during the start and maintenance of general anesthesia (inpatient and outpatient procedures)
  • Continued pain control in the immediate period after surgery in adults, under direct supervision of an anesthesia practitioner in a recovery or intensive care setting
  • Pain control as part of monitored anesthesia care in adults

How It Works

Remifentanil is a μ-opioid agonist. It attaches to opioid receptors to reduce pain. It acts quickly and wears off quickly.

Unlike most opioids, it is broken down by esterases in blood and tissues, not by the liver. Opioid blockers such as naloxone can reverse its effects.

Drug Class

Drug Class

  • Opioid Agonist
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Opioid Agonist

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)
  • Full Opioid Agonists

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Remifentanil in the FDA’s index.

From our Patient Information GuideRemifentanil is a μ-opioid agonist. It attaches to opioid receptors to reduce pain. It acts quickly and wears off quickly. Unlike most opioids, it is broken down by esterases in blood and tissues, not by the liver. Read How Remifentanil Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)

None listed for Remifentanil in the FDA’s index.

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Opioid anesthetics

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Remifentanil is given only into a vein by trained anesthesia staff, either as a continuous infusion through a pump or as occasional extra doses during anesthesia. It must be diluted first.

Your team adjusts the amount based on how you respond, and starting doses are lower for adults over 65.

  • It is not taken at home, so there are no missed doses to manage
  • Pain control is planned before the infusion ends because effects fade quickly

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Pain control during general anesthesia

Adults · Induction Starting dose 1 mcg/kg
  • Continuous IV infusion 0.5 – 1 mcg/kg/min
  • An initial dose of 1 mcg/kg may be administered over 30 to 60 seconds

IV means given into a vein (intravenous).

Adults · Maintenance with nitrous oxide (66%) Dose 1 mcg/kg
  • Continuous IV infusion 0.4 mcg/kg/min (range 0.1 – 2 mcg/kg/min)
  • Supplemental IV bolus 1 mcg/kg

IV means given into a vein (intravenous).

Adults · Maintenance with isoflurane (0.4 to 1.5 MAC) Dose 1 mcg/kg
  • Continuous IV infusion 0.25 mcg/kg/min (range 0.05 – 2 mcg/kg/min)
  • Supplemental IV bolus 1 mcg/kg

IV means given into a vein (intravenous).

Adults · Maintenance with propofol (100 to 200 mcg/kg/min) Dose 1 mcg/kg
  • Continuous IV infusion 0.25 mcg/kg/min (range 0.05 – 2 mcg/kg/min)
  • Supplemental IV bolus 1 mcg/kg

IV means given into a vein (intravenous).

Babies from birth to 2 months old · Maintenance with nitrous oxide (70%) Dose 1 mcg/kg
  • Continuous IV infusion 0.4 mcg/kg/min (range 0.4 – 1.0 mcg/kg/min)
  • Supplemental IV bolus 1 mcg/kg

Good to know

Clearance in neonates is highly variable, on average two times higher than in young healthy adults; increased infusion rate or additional boluses may be needed

IV means given into a vein (intravenous).

Children 1 to 12 years old · Maintenance with halothane (0.3 to 1.5 MAC) Dose 1 mcg/kg
  • Continuous IV infusion 0.25 mcg/kg/min (range 0.05 – 1.3 mcg/kg/min)
  • Supplemental IV bolus 1 mcg/kg

IV means given into a vein (intravenous).

Children 1 to 12 years old · Maintenance with sevoflurane (0.3 to 1.5 MAC) Dose 1 mcg/kg
  • Continuous IV infusion 0.25 mcg/kg/min (range 0.05 – 1.3 mcg/kg/min)
  • Supplemental IV bolus 1 mcg/kg

IV means given into a vein (intravenous).

Children 1 to 12 years old · Maintenance with isoflurane (0.4 to 1.5 MAC) Dose 1 mcg/kg
  • Continuous IV infusion 0.25 mcg/kg/min (range 0.05 – 1.3 mcg/kg/min)
  • Supplemental IV bolus 1 mcg/kg

IV means given into a vein (intravenous).

Pain control after surgery in a recovery or intensive care setting

For adults
Continuous IV infusion 0.1 mcg/kg/min (range 0.025 – 0.2 mcg/kg/min); supplemental bolus not recommended

IV means given into a vein (intravenous).

Pain control during monitored anesthesia care

Adults · Single dose, Ultiva alone Usual dose 1 mcg/kg once
  • 1 mcg/kg over 30 to 60 seconds, given 90 seconds before local anesthetic
Adults also given 2 mg midazolam · Single dose with midazolam Usual dose 0.5 mcg/kg once
  • 0.5 mcg/kg over 30 to 60 seconds, given 90 seconds before local anesthetic
Adults · Continuous infusion, Ultiva alone 0.1 mcg/kg/min beginning 5 minutes before local anesthetic; after local anesthetic 0.05 mcg/kg/min (range 0.025 to 0.2 mcg/kg/min)
Adults also given 2 mg midazolam · Continuous infusion with midazolam 0.05 mcg/kg/min beginning 5 minutes before local anesthetic; after local anesthetic 0.025 mcg/kg/min (range 0.025 to 0.2 mcg/kg/min)

Pain control during coronary artery bypass surgery

For adults · Maintenance
Dose 0.5 to 1 mcg/kg
  • Continuous IV infusion 1 mcg/kg/min (range 0.125 to 4 mcg/kg/min)
  • Supplemental IV bolus 0.5 to 1 mcg/kg

IV means given into a vein (intravenous).

See the Full Dosing Instructions on DailyMed →

Side Effects

The most common side effects are related to how opioids affect the body.

Common side effects

  • Slowed or shallow breathing (respiratory depression)
  • Slow heart rate (bradycardia)
  • Low blood pressure (hypotension)
  • Muscle stiffness or rigidity
  • Nausea and vomiting

When to get medical help

  • Trouble breathing, very slow breathing, or extreme sleepiness: tell your care team right away
  • Chest or muscle stiffness that makes breathing difficult
  • Signs of serotonin syndrome, such as agitation, hallucinations, fast heartbeat, fever, stiff or twitching muscles, or diarrhea
  • Pain that gets worse or feels more sensitive after opioid dose increases (opioid-induced hyperalgesia)
  • Severe allergic reaction (anaphylaxis)
  • Dizziness or fainting from low blood pressure
  • Worsening seizures if you have a seizure disorder

Warnings and Precautions

  • Breathing depression: can be fatal. Risk is highest at the start or after a dose increase, and in people with COPD, older adults, or frail patients.
  • Addiction, abuse, and misuse: it is a Schedule II controlled substance.
  • Sedatives and alcohol: combined use can cause profound sedation, coma, and death.
  • Muscle and chest wall rigidity: related to dose and speed of administration.
  • Slow heart rate and low blood pressure: monitored during dosing.
  • Awareness during surgery: reported in patients under 55 when used with low propofol infusion rates.
  • Opioid-induced hyperalgesia: pain that paradoxically worsens.
  • Serotonin syndrome: a potentially life-threatening reaction with serotonergic drugs.

Interactions

Several medicines can add to remifentanil's effects or cause dangerous reactions.

  • Benzodiazepines, sedatives, muscle relaxants, antipsychotics, other opioids: more sedation and breathing depression
  • Alcohol: avoid for 24 hours after surgery
  • Serotonergic drugs (SSRIs, SNRIs, tricyclics, triptans, tramadol, linezolid, methylene blue): risk of serotonin syndrome
  • MAO inhibitors: not recommended within 14 days of use
  • Buprenorphine, butorphanol, nalbuphine, pentazocine: may reduce pain relief or trigger withdrawal
  • Blood products in the same IV line: may inactivate remifentanil

Interactions Listed in the FDA-Approved Label

From the Remifentanil prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Benzodiazepines and other CNS depressants For example: alcohol
    What happensAdditive effects increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.
    What to doLimit dosages and durations to the minimum required; follow patients closely for respiratory depression and sedation; advise avoiding alcohol for 24 hours after surgery.
  • Serotonergic drugs
    What happensConcomitant use of opioids with drugs affecting the serotonin system has resulted in serotonin syndrome.
    What to doIf concomitant use is warranted, observe the patient carefully, especially at treatment start and dose adjustment; discontinue remifentanil if serotonin syndrome is suspected.
  • Monoamine oxidase inhibitors (MAOIs)
    What happensInteractions with opioids may appear as serotonin syndrome or opioid toxicity (e.g., respiratory depression, coma).
    What to doNot recommended in patients taking MAOIs or within 14 days of stopping them; if urgent use is necessary, use test doses and frequent titration of small doses while closely monitoring blood pressure and CNS and respiratory depression.
  • Mixed agonist/antagonist and partial agonist opioid analgesics (butorphanol, nalbuphine, pentazocine, buprenorphine)
    What happensMay reduce the analgesic effect of remifentanil and/or precipitate withdrawal symptoms.
    What to doIf concomitant use is warranted, observe the patient carefully, especially at treatment start and dose adjustment; consider discontinuing remifentanil if the patient is not responding appropriately and institute alternative analgesic treatment.
  • Succinylcholine
    What happensIn animals the duration of muscle paralysis from succinylcholine is not prolonged by remifentanil.
Read the label’s full interactions text

7 DRUG INTERACTIONS Table 18 includes clinically significant drug interactions with remifentanil Hydrochloride for injection. Table 18: Clinically Significant Drug Interactions with Remifentanil Hydrochloride for Injection Benzodiazepines and other Central Nervous System (CNS) Depressants Clinical Impact: Due to additive pharmacologic effect, the concomitant use of benzodiazepines or other CNS depressants including alcohol, increases the risk of hypotension, respiratory depression, profound sedation, coma, and death. Intervention: Limit dosages and durations to the minimum required. Follow patients closely for signs of respiratory depression and sedation. Patients should be advised to avoid alcohol for 24 hours after surgery. Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, other opioids, alcohol. Serotonergic Drugs Clinical Impact: The concomitant use of opioids with other drugs that affect the serotonergic neurotransmitter system has resulted in serotonin syndrome. Intervention: If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. Discontinue Remifentanil Hydrochloride for injection if serotonin syndrome is suspected. Examples: Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 receptor antagonists, drugs that effect the serotonin neurotransmitter system (e.g., mirtazapine, trazodone, tramadol), certain muscle relaxants (i.e., cyclobenzaprine, metaxalone), monoamine oxidase (MAO) inhibitors (those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue).

Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Not for epidural or intrathecal use
  • Not for people with a hypersensitivity (such as anaphylaxis) to remifentanil
  • Use extra caution with COPD, reduced breathing reserve, head injury, brain tumor, seizure disorders, biliary tract disease, or low blood volume
  • Pregnancy: may cause fetal harm; not recommended during or just before labor when other options are more appropriate
  • Breastfeeding: watch the infant for sedation and breathing problems
  • Children: not studied for postoperative pain or monitored anesthesia care
  • Older adults: more sensitive, with starting doses cut by 50%; kidney function may matter
  • Severe obesity calls for extra caution

Overdose

Overdose can cause very slow breathing, deep sleepiness progressing to coma, cold clammy skin, small pupils, slow heart rate, and low blood pressure. Treatment focuses on protecting the airway and supporting breathing. The infusion is stopped, and reversal medicines such as naloxone or nalmefene may be given if breathing or circulation is seriously affected.

Half-Life and How Your Body Processes It

Remifentanil's effective half-life is only about 3 to 10 minutes, and its duration does not lengthen with prolonged infusion. It is broken down mainly by esterases in blood and tissues, not the liver. Its nearly inactive breakdown product is cleared by the kidneys. Liver or kidney impairment does not change how remifentanil itself is processed.

Storage

Stored at 2° to 25°C (36° to 77°F).

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Remifentanil: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Remifentanil — the kind of thing our pharmacy team would talk through with you at the counter.

What is remifentanil used for?

It is an IV opioid pain medicine used by anesthesia teams. It helps control pain during general anesthesia, after surgery in adults in a monitored recovery setting, and during monitored anesthesia care in adults.

How long does remifentanil last?

Not long. It starts working within minutes and wears off within about 5 to 10 minutes after the infusion stops. Because of this, your team will plan other pain relief before stopping it.

Can I drink alcohol after surgery with remifentanil?

Avoid alcohol for 24 hours after surgery. Alcohol adds to opioid effects and can cause dangerous sedation and breathing problems.

What side effects should I expect?

Slowed breathing, slow heart rate, low blood pressure, muscle stiffness, and nausea can happen. Your team monitors you closely. Tell them right away if you have trouble breathing or feel very sleepy or dizzy.

Do I need to worry about other medicines I take?

Yes, tell your team about everything you take. Sedatives, sleep aids, other opioids, antidepressants, migraine triptans, and MAO inhibitors can interact with remifentanil.

Is remifentanil safe in pregnancy or while breastfeeding?

It may cause fetal harm and is not recommended around labor when other pain options are more appropriate. If you breastfeed, your baby should be watched for extra sleepiness and breathing problems.

Is remifentanil available over the counter?

No. Remifentanil is a prescription medicine: every remifentanil product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

Is remifentanil a controlled substance?

Yes — remifentanil is a federally controlled substance (Schedule II) in the United States, so how it is prescribed, refilled and dispensed is regulated by the DEA.

When was remifentanil first available?

The earliest FDA record we hold for remifentanil is from 1996: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when remifentanil was first used.

Who makes remifentanil?

3 companies currently list remifentanil products in the FDA's NDC Directory, including Mylan Institutional LLC, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA Inc.. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of remifentanil?

Remifentanil is the generic name. Its brand name is Ultiva. Generic versions are listed under the name remifentanil.

What is the generic name of Ultiva?

The generic name of Ultiva is remifentanil. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is remifentanil?

Remifentanil belongs to the drug class Opioid Agonist, its established pharmacologic class on the FDA label.

Is there a generic version of remifentanil?

Yes. FDA-approved generic versions of remifentanil are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does remifentanil come in?

Remifentanil is listed in the FDA's National Drug Code Directory in these forms and strengths. Injection (into a vein): 2 mg/2 mL and 5 mg/5 mL. A listing does not mean every pharmacy stocks every strength.

Is there a remifentanil shortage?

Yes. Remifentanil is on the FDA's drug shortage list as of Nov 22, 2026. A shortage means some products are hard to get, not that every pharmacy is out. The shortage page lists the affected products and what each company has told the FDA. Read the remifentanil shortage page

Where can I read the remifentanil prescribing information (package insert)?

The full FDA-approved prescribing information for remifentanil, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Mylan Institutional LLC's, revised Dec 15, 2025, and links to it on DailyMed.

Is remifentanil gluten free?

No remifentanil label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 12 remifentanil products from 3 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's remifentanil by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See remifentanil inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Remifentanil

Skip the scrolling. Ask in your own words and get an answer from Remifentanil’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Remifentanil’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Remifentanil on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Remifentanil Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Remifentanil Forms and Strengths (How It Comes)

Remifentanil comes in 1 dose form, the injection. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Remifentanil inactive ingredients by manufacturer.

Injection

Into a vein
Brands Ultiva (the first brand, 1996)
How this form is used
What it may be used for
  • Remifentanil Hydrochloride for injection is used for pain control during general anesthesia, right after surgery in adults, and in adult monitored anesthesia care
  • Ultiva is used for pain control during general anesthesia, right after surgery in adults, and in adult monitored anesthesia care
Important instructions
  • Ultiva is for IV use only and must be diluted before use
  • Remifentanil Hydrochloride for injection is for IV use only and must be diluted before use
  • Ultiva continuous infusions are given only with an infusion device, and unused portions are discarded
  • Ultiva IV tubing should be cleared after stopping to prevent accidental later doses
Available strengths 3 strengths
12 FDA-listed product records ⓘ

Remifentanil on the U.S. Market: Products, Makers and Brands

How Remifentanil appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

3 companies list 12 Remifentanil product records with the FDA, mostly as injection; the earliest marketing or approval year on record is 1996. The one brand name in the directory today is Ultiva; the rest are generics.

1
Dose forms ⓘ
3
Labelers (makers, repackagers, distributors)
1
Brand names ⓘ
12
FDA-listed product records ⓘ
1996
Earliest FDA record ⓘ

Also listed with the FDA, not a patient dose form: Powder (6) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

Mylan Institutional LLC50%
Fresenius Kabi USA, LLC25%
Hikma Pharmaceuticals USA Inc.25%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Remifentanil Is Used (Medicaid Data)

How many Remifentanil prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

842
Medicaid prescriptions filled (Q1–Q4 2025)
$45,797 paid by Medicaid, before rebates

How commonly is Remifentanil prescribed? Of the 1,682 medications we measure, Remifentanil ranks #1,359 by Medicaid prescriptions — more than 19% of them.

Where Remifentanil ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Remifentanil product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 2 mg injection is the most-dispensed Remifentanil product — about 52% of these Medicaid prescriptions.

remifentanil 2 MG Injection Most dispensed

440 Medicaid prescriptions (Q1–Q4 2025) 52% of Remifentanil prescriptions shown $15,012 paid by Medicaid, before rebates ≈ $34 per prescription, before rebates

3 of 11 listed NDCs had Medicaid claims. RxNorm 1729584

remifentanil 1 MG Injection

402 Medicaid prescriptions (Q1–Q4 2025) 48% of Remifentanil prescriptions shown $30,785 paid by Medicaid, before rebates ≈ $77 per prescription, before rebates

3 of 11 listed NDCs had Medicaid claims. RxNorm 1729578

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 6 of the 22 listed Remifentanil NDCs had Medicaid claims.

Compare Remifentanil Products

A representative set of FDA-listed product records for Remifentanil — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Strength Route Manufacturer / Labeler Category ⓘ Details
💊Injection
1 mg/mL Intravenous Fresenius Kabi USA, LLC × 3 listings ANDA View NDC →
1 mg/mL Intravenous Hikma Pharmaceuticals USA Inc. ANDA View NDC →
2 mg/2 mL Intravenous Hikma Pharmaceuticals USA Inc. ANDA View NDC →
5 mg/5 mL Intravenous Hikma Pharmaceuticals USA Inc. ANDA View NDC →
1 mg/mL Intravenous Mylan Institutional LLC × 6 listings NDA View NDC →

Showing 12 of 12 products — FDA National Drug Code Directory. See every product, package size and price: browse all 12 Remifentanil NDCs →

Remifentanil Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Remifentanil recalls since July 2021.

✅No Remifentanil recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Remifentanil in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
1
Strengths
3
Forms in current FDA listings
1 of 1
In current FDA listings No current FDA listing
Ingredient (IN) Remifentanil RxCUI 73032
  1. Dose form (SCDF) Injection RxCUI 1729577
    In current FDA listings
    Its 3 strengths (SCD)

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

Remifentanil Brand Names

Remifentanil has one brand name on record: Ultiva. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Ultiva the first brand, 1996

Who Makes Remifentanil: Manufacturers and Labelers

3 companies list Remifentanil products with the FDA. By number of product records, the largest are Mylan Institutional LLC, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Mylan Institutional LLC 6 Fresenius Kabi USA, LLC 3 Hikma Pharmaceuticals USA Inc. 3

Sources for This Remifentanil Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Dec 15, 2025, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Remifentanil.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 4 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
4
Finished products in the current FDA directory
12
Companies listing them (makers, repackagers, distributors)
3
FDA labeler codes behind them ⓘ
4
Linked representative label ⓘ
Mylan Institutional LLC
Linked label effective
Dec 15, 2025
Composite sections available
24
Linked SPL Set ID
4dbcb8f9-1987-4b66-bd2f-d251fda0be10
Linked SPL Document ID
c60a1e36-91ef-4360-92b8-79e120304b6e
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Mylan Institutional LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →